GeneDx Holdings (WGS) Equity Ratio (2020 - 2025)
Historic Equity Ratio for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to 0.59.
- GeneDx Holdings' Equity Ratio rose 1829.97% to 0.59 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.59, marking a year-over-year increase of 1829.97%. This contributed to the annual value of 0.58 for FY2024, which is 739.64% up from last year.
- According to the latest figures from Q3 2025, GeneDx Holdings' Equity Ratio is 0.59, which was up 1829.97% from 0.6 recorded in Q2 2025.
- GeneDx Holdings' 5-year Equity Ratio high stood at 0.7 for Q4 2021, and its period low was 3.23 during Q2 2021.
- In the last 5 years, GeneDx Holdings' Equity Ratio had a median value of 0.59 in 2025 and averaged 0.24.
- Per our database at Business Quant, GeneDx Holdings' Equity Ratio surged by 565773.58% in 2021 and then crashed by 2622.07% in 2022.
- GeneDx Holdings' Equity Ratio (Quarter) stood at 0.7 in 2021, then decreased by 26.22% to 0.52 in 2022, then increased by 5.37% to 0.54 in 2023, then rose by 7.4% to 0.58 in 2024, then increased by 1.19% to 0.59 in 2025.
- Its last three reported values are 0.59 in Q3 2025, 0.6 for Q2 2025, and 0.58 during Q1 2025.